HOTCHKIS & WILEY's CVS Position Overview
HOTCHKIS & WILEY (via Hotchkis & Wiley Capital Management LLC) currently holds 2.88 M shares of CVS Health Corporation (CVS) worth $217.14 M, representing 0.67% of the portfolio. First purchased in 2021-Q2, this medium-term investment has been held for 18 quarters.
Based on 13F filings, HOTCHKIS & WILEY has maintained a strategic position in CVS, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2024, adding 3.07 M shares. Largest reduction occurred in Q1 2025, reducing 5.16 M shares.
Analysis based on 13F filings available since 2013 Q2
HOTCHKIS & WILEY's CVS Health Corporation (CVS) Holding Value Over Time
Track share changes against reported price movement
Quarterly CVS Health Corporation (CVS) Trades by HOTCHKIS & WILEY
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q2 2021 | +3.5 M | New Buy | 3.5 M | $83.44 |
| Q3 2021 | +191,375 | Add 5.47% | 3.69 M | $84.86 |
| Q4 2021 | +369,746 | Add 10.03% | 4.06 M | $103.16 |
| Q1 2022 | -585,725 | Reduce 14.44% | 3.47 M | $101.21 |
| Q2 2022 | -82,084 | Reduce 2.36% | 3.39 M | $92.66 |
| Q3 2022 | -77,982 | Reduce 2.30% | 3.31 M | $95.37 |
| Q4 2022 | -165,548 | Reduce 5.00% | 3.15 M | $93.19 |
| Q1 2023 | +2.19 M | Add 69.47% | 5.33 M | $74.31 |
| Q2 2023 | +1 M | Add 18.81% | 6.33 M | $69.13 |
| Q3 2023 | +515,325 | Add 8.14% | 6.85 M | $69.82 |
| Q4 2023 | -152,810 | Reduce 2.23% | 6.7 M | $78.96 |
| Q1 2024 | -48,486 | Reduce 0.72% | 6.65 M | $79.76 |
| Q2 2024 | +2.18 M | Add 32.76% | 8.83 M | $59.06 |
| Q3 2024 | +3.07 M | Add 34.80% | 11.9 M | $62.88 |
| Q4 2024 | +1.04 M | Add 8.77% | 12.94 M | $44.89 |
| Q1 2025 | -5.16 M | Reduce 39.90% | 7.78 M | $67.75 |
| Q2 2025 | -2.23 M | Reduce 28.72% | 5.54 M | $68.98 |
| Q3 2025 | -2.66 M | Reduce 48.04% | 2.88 M | $75.39 |
HOTCHKIS & WILEY's CVS Health Corporation Investment FAQs
HOTCHKIS & WILEY first purchased CVS Health Corporation (CVS) in Q2 2021, acquiring 3,495,808 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY has held CVS Health Corporation (CVS) for 18 quarters since Q2 2021. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY's largest addition to CVS Health Corporation (CVS) was in Q2 2021, adding 3,495,808 shares worth $291.69 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, HOTCHKIS & WILEY's firm, Hotchkis & Wiley Capital Management LLC, owns 2,880,247 shares of CVS Health Corporation (CVS), valued at approximately $217.14 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, CVS Health Corporation (CVS) represents approximately 0.67% of HOTCHKIS & WILEY's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
HOTCHKIS & WILEY's peak holding in CVS Health Corporation (CVS) was 12,939,987 shares, as reported at the end of Q4 2024. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.